Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innospec (IOSP) Cost of Revenue (2016 - 2025)

Innospec's Cost of Revenue history spans 16 years, with the latest figure at $328.2 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 0.73% year-over-year to $328.2 million; the TTM value through Dec 2025 reached $1.3 billion, down 1.3%, while the annual FY2025 figure was $1.3 billion, 1.3% down from the prior year.
  • Cost of Revenue for Q4 2025 was $328.2 million at Innospec, up from $325.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $361.8 million in Q1 2023 and bottomed at $238.8 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $327.3 million (2022), against an average of $318.6 million.
  • The largest annual shift saw Cost of Revenue surged 41.2% in 2021 before it decreased 8.43% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $300.3 million in 2021, then rose by 19.58% to $359.1 million in 2022, then dropped by 5.6% to $339.0 million in 2023, then fell by 2.48% to $330.6 million in 2024, then decreased by 0.73% to $328.2 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Cost of Revenue are $328.2 million (Q4 2025), $325.2 million (Q3 2025), and $316.5 million (Q2 2025).